Lentiviral Gene Therapy in HSCs Restores Lineage-Specific Foxp3 Expression and Suppresses Autoimmunity in a Mouse Model of IPEX Syndrome.

[1]  J. Hauber,et al.  Improving Lentiviral Transduction of CD34+ Hematopoietic Stem and Progenitor Cells. , 2018, Human gene therapy methods.

[2]  F. Rieux-Laucat,et al.  Long-term follow-up of IPEX syndrome patients after different therapeutic strategies: An international multicenter retrospective study , 2017, The Journal of allergy and clinical immunology.

[3]  L. Naldini,et al.  Ectopic FOXP3 Expression Preserves Primitive Features Of Human Hematopoietic Stem Cells While Impairing Functional T Cell Differentiation , 2017, Scientific Reports.

[4]  David Gray,et al.  Hematopoietic Stem Cell Gene Therapy: Progress and Lessons Learned. , 2017, Cell stem cell.

[5]  P. Zhu,et al.  Functional defects in CD4+ CD25high FoxP3+ regulatory cells in ankylosing spondylitis , 2016, Scientific Reports.

[6]  Harri Lähdesmäki,et al.  Control of Foxp3 stability through modulation of TET activity , 2016, The Journal of experimental medicine.

[7]  Michael L Kaufman,et al.  Enrichment of Human Hematopoietic Stem/Progenitor Cells Facilitates Transduction for Stem Cell Gene Therapy , 2015, Stem cells.

[8]  C. Benner,et al.  Function of a Foxp3 cis-Element in Protecting Regulatory T Cell Identity , 2014, Cell.

[9]  M. Wunderlich,et al.  OKT3 prevents xenogeneic GVHD and allows reliable xenograft initiation from unfractionated human hematopoietic tissues. , 2014, Blood.

[10]  L. Naldini,et al.  CD4+ T Cells from IPEX Patients Convert into Functional and Stable Regulatory T Cells by FOXP3 Gene Transfer , 2013, Science Translational Medicine.

[11]  R. Geffers,et al.  Active Demethylation of the Foxp3 Locus Leads to the Generation of Stable Regulatory T Cells within the Thymus , 2013, The Journal of Immunology.

[12]  S. Shurtleff,et al.  Therapeutic in vivo selection of thymic-derived natural T regulatory cells following non-myeloablative hematopoietic stem cell transplant for IPEX. , 2011, Clinical immunology.

[13]  Aaron R Cooper,et al.  Highly efficient large-scale lentiviral vector concentration by tandem tangential flow filtration. , 2011, Journal of virological methods.

[14]  A. Rudensky,et al.  Role of conserved non-coding DNA elements in the Foxp3 gene in regulatory T-cell fate , 2010, Nature.

[15]  S. Ziegler,et al.  CD4+FOXP3+ regulatory T cells confer long-term regulation of factor VIII-specific immune responses in plasmid-mediated gene therapy-treated hemophilia mice. , 2009, Blood.

[16]  T. Lion,et al.  Selective engraftment of donor CD4+25high FOXP3-positive T cells in IPEX syndrome after nonmyeloablative hematopoietic stem cell transplantation. , 2009, Blood.

[17]  James L Riley,et al.  Human T regulatory cell therapy: take a billion or so and call me in the morning. , 2009, Immunity.

[18]  A. Logan,et al.  Factors influencing the titer and infectivity of lentiviral vectors. , 2004, Human gene therapy.

[19]  F. Ramsdell,et al.  An essential role for Scurfin in CD4+CD25+ T regulatory cells , 2003, Nature Immunology.

[20]  A. Rudensky,et al.  Foxp3 programs the development and function of CD4+CD25+ regulatory T cells , 2003, Nature Immunology.

[21]  M. Mortrud,et al.  The Amount of Scurfin Protein Determines Peripheral T Cell Number and Responsiveness1 , 2001, The Journal of Immunology.

[22]  H. Ochs,et al.  The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3 , 2001, Nature Genetics.

[23]  J. Casanova,et al.  X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy , 2001, Nature Genetics.

[24]  D. Galas,et al.  Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse , 2001, Nature Genetics.

[25]  D. Trono,et al.  A Third-Generation Lentivirus Vector with a Conditional Packaging System , 1998, Journal of Virology.